← All trials
NCT02684747
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 29, 2016
- Primary completion
- May 5, 2018
- Completion date
- May 5, 2018
- First posted
- Feb 18, 2016
- Last posted
- May 14, 2018
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of UtahLead sponsor
- Partnership for Clean CompetitionCollaborator
- Sports Medicine Research and Testing LaboratoryCollaborator
- University of UtahOverall official - principal investigator
- University of UtahReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.